Regenerative biotechnology
Gencell®: Allogeneic fibroblasts
Allogeneic fibroblasts derived from placenta for skin rejuvenation.
Injectable solution of allogeneic fibroblasts derived from placenta, indicated for facial rejuvenation procedures through subdermal application, aimed at restoring the structure, function, and quality of aged skin.
Composition
Allogeneic fibroblasts derived from placenta.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
Promotes skin repair through cellular migration, release of regenerative cytokines, inhibition of metalloproteinases, stimulation of dermal fibroblasts, and increased collagen, extracellular matrix, skin thickness, and vascularization.
- Improves skin texture.
- Reduces visible wrinkles.
- Increases skin firmness.
- Increases skin elasticity.
- Stimulates collagen production.
- Promotes tissue regeneration.
- Inhibits degradation of the extracellular matrix.
- Contributes to a more youthful appearance.
Mechanism of action & Clinical data
Migrates to sites of skin damage, releases regenerative cytokines, inhibits metalloproteinases, and stimulates dermal fibroblasts, promoting tissue repair and structural restoration of the skin.